The antitumor immunity of FasL-transfected Lewis lung carcinoma enhanced by cyclooxygenase-2 inhibitor
碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 92 === Abstrsct The Fas ligand (FasL) induces programmed cell death via interaction with its receptor Fas. It has been proposed that expression of FasL can confer immune privilege to some organs, allowing them to kill infiltrating lymphocytes and inflammatory cells....
Main Authors: | Ren-Shiang Jhou, 周仁祥 |
---|---|
Other Authors: | Shye-Jye Tang |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/33719154880866707166 |
Similar Items
-
Enhancing Antitumor Immunity of FasL-Transfected Lewis Lung Carcinoma Is Used by Dendritic Cell-Based Vaccine
by: Yi-Lin Tsai, et al.
Published: (2004) -
Induction of antitumor immunity with injection of Fas Ligand (CD95L )-transfected Lewis lung carcinoma in mice
by: 朱嘉憶
Published: (2002) -
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
by: Han Jae, et al.
Published: (2008-11-01) -
FAS AND FASL EXPRESSION IN MAMMARY CARCINOMAS
by: Dorina Munteanu, et al.
Published: (2004-08-01) -
Apoptosis and Fas/FasL Pathway: role of FAS and FASL Functional Polymorphisms in Prostate Cancer development
by: Lima, Luís Carlos Oliveira
Published: (2011)